Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

December 01, 2016; Volume 359,Issue 3

Behavioral Pharmacology

  • You have access
    Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys
    Lisa R. Gerak, Gregory T. Collins and Charles P. France
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 383-391; DOI: https://doi.org/10.1124/jpet.116.236307
  • Open Access
    Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
    N. Levy-Cooperman, G. McIntyre, L. Bonifacio, M. McDonnell, J. M. Davenport, P. S. Covington, L. S. Dove and E. M. Sellers
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 471-481; DOI: https://doi.org/10.1124/jpet.116.236547

Cellular and Molecular

  • You have access
    Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons
    Laura C. Sullivan, Teresa S. Chavera, Raehannah J. Jamshidi, Kelly A. Berg and William P. Clarke
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 411-419; DOI: https://doi.org/10.1124/jpet.116.232835

Drug Discovery and Translational Medicine

  • You have access
    Akebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation
    Li-li Gong, Guang-run Li, Wen Zhang, He Liu, Ya-li Lv, Fei-fei Han, Zi-rui Wan, Ming-biao Shi and Li-hong Liu
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 392-400; DOI: https://doi.org/10.1124/jpet.116.236562

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity
    Edwin K. Jackson, Delbert G. Gillespie and Zaichuan Mi
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 420-435; DOI: https://doi.org/10.1124/jpet.116.237552
  • You have access
    Contribution of GABAA, Glycine, and Opioid Receptors to Sacral Neuromodulation of Bladder Overactivity in Cats
    Xuewen Jiang, Thomas W. Fuller, Jathin Bandari, Utsav Bansal, Zhaocun Zhang, Bing Shen, Jicheng Wang, James R. Roppolo, William C. de Groat and Changfeng Tai
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 436-441; DOI: https://doi.org/10.1124/jpet.116.235846
  • You have access
    Potential L-Type Voltage–Operated Calcium Channel Blocking Effect of Drotaverine on Functional Models
    Zoltán Patai, András Guttman and Endre G. Mikus
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 442-451; DOI: https://doi.org/10.1124/jpet.116.237271

Inflammation, Immunopharmacology, and Asthma

  • Open Access
    Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration
    Boris M. Baranovski, Eyal Ozeri, Galit Shahaf, David E. Ochayon, Ronen Schuster, Nofar Bahar, Noa Kalay, Pablo Cal, Mark I. Mizrahi, Omer Nisim, Pnina Strauss, Eran Schenker and Eli C. Lewis
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 482-490; DOI: https://doi.org/10.1124/jpet.116.236067

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation
    Jia Yin, Haichuan Duan and Joanne Wang
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 401-410; DOI: https://doi.org/10.1124/jpet.116.236158
  • You have access
    Blood–Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate
    Therese S. Salameh, Gul N. Shah, Tulin O. Price, Melvin R. Hayden and William A. Banks
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 452-459; DOI: https://doi.org/10.1124/jpet.116.237057

Neuropharmacology

  • Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata
    You have access
    Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata
    Martin J. Bobak, Matthew W. Weber, Melissa A. Doellman, Douglas R. Schuweiler, Jeana M. Athens, Steven A. Juliano and Paul A. Garris
    Journal of Pharmacology and Experimental Therapeutics December 2016, 359 (3) 460-470; DOI: https://doi.org/10.1124/jpet.116.236000
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 359 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 359, Issue 3
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Behavioral Pharmacology
  • Cellular and Molecular
  • Drug Discovery and Translational Medicine
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Nose-to-Brain Delivery
  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics